Tal Gefen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tal Gefen has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Assaf Rotem
47 Bow Rd, Newton MA 02459
1 shared publication - Daniel A. King
Daniel A. King is a senior physician in the intensive care unit, Rambam Health Care Campus, Haifa, Israel; Pulmonary Department, Meir Medical Center, Kfar Saba, Israel; and the Sackler Faculty of Medicine, Tel Aviv, Israel
1 shared publication - Haitham Hajjo
Technion-Israel Institute of Technology
1 shared publication - Lilach Elbaum
Technion-Israel Institute of Technology
1 shared publication - Mical Paul
Unit of Infectious Diseases, Rambam Health Care Campus, HaAliya HaShniya St 8, Haifa, Israel
1 shared publication - Michal Chowers
Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel; Infectious Diseases Unit, Meir Medical Center, Kfar Saba, Israel
1 shared publication
Latest Publications
- Open Access
SARS-CoV-2 On-the-Spot Virus Detection Directly from Patients
Many countries are currently in a lockdown state due to the SARS-CoV-2 pandemic. One key aspect to transition safely out of lockdown is to continuously test the population for infected subjects. Currently, detection is performed at points of care using quantitative reverse-transcription PCR (RT-qPCR), and requires dedicated professionals and equipment. Here, we developed a protocol based on Reverse Transcribed Loop-Mediated Isothermal Amplification (RT-LAMP) for detection of SARS-CoV-2. This protocol is applied directly on SARS-CoV-2 nose and throat swabs, with no RNA purification step required. We tested this protocol on over 180 suspected patients, and compared its results to the standard method. We further succeeded to apply the protocol on self-sampled saliva from confirmed cases. Since the proposed protocol provides results on-the-spot, and can detect SARS-CoV-2 from saliva, it can allow simple and continuous surveillance of the community.
Open AccessSARS-CoV-2 On-the-Spot Virus Detection Directly from Patients
Many countries are currently in a lockdown state due to the SARS-CoV-2 pandemic. One key aspect to transition safely out of lockdown is to continuously test the population for infected subjects. Currently, detection is performed at points of care using quantitative reverse-transcription PCR (RT-qPCR), and requires dedicated professionals and equipment. Here, we developed a protocol based on Reverse Transcribed Loop-Mediated Isothermal Amplification (RT-LAMP) for detection of SARS-CoV-2. This protocol is applied directly on SARS-CoV-2 nose and throat swabs, with no RNA purification step required. We tested this protocol on over 180 suspected patients, and compared its results to the standard method. We further succeeded to apply the protocol on self-sampled saliva from confirmed cases. Since the proposed protocol provides results on-the-spot, and can detect SARS-CoV-2 from saliva, it can allow simple and continuous surveillance of the community.